These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23906114)

  • 41. High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline.
    Gaetani L; Fanelli F; Riccucci I; Eusebi P; Sarchielli P; Pozzilli C; Calabresi P; Prosperini L; Di Filippo M
    J Neurol Sci; 2017 Aug; 379():236-240. PubMed ID: 28716249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Explanation of Multiple Sclerosis Diagnostic Criteria].
    Nakashima I
    Brain Nerve; 2020 May; 72(5):485-491. PubMed ID: 32381746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis].
    Zakharov AV; Khinivtseva EV; Poverennova IE; Gindullina EA; Vlasov IaV; Sineok EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):28-31. PubMed ID: 23528591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Brain MRI findings in Japanese patients with clinically isolated syndrome].
    Tanaka M; Motoyama R; Tahara M; Tanaka K
    Rinsho Shinkeigaku; 2012; 52(10):725-9. PubMed ID: 23064621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion Predictors of Clinically Isolated Syndrome to Multiple Sclerosis in Mexican Patients: A Prospective Study.
    Chavarria V; Espinosa-Ramírez G; Sotelo J; Flores-Rivera J; Anguiano O; Hernández AC; Guzmán-Ríos ED; Salazar A; Ordoñez G; Pineda B
    Arch Med Res; 2023 Jul; 54(5):102843. PubMed ID: 37429750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
    Brownlee WJ; Swanton JK; Miszkiel KA; Miller DH; Ciccarelli O
    Neurology; 2016 Aug; 87(7):680-3. PubMed ID: 27421541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes.
    Mitjana R; Tintoré M; Rocca MA; Auger C; Barkhof F; Filippi M; Polman C; Fazekas F; Huerga E; Montalban X; Rovira A
    Mult Scler; 2014 Oct; 20(11):1471-7. PubMed ID: 24576831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
    Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
    Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
    Trabatti C; Foiadelli T; Spartà MV; Gagliardone C; Rinaldi B; Delmonte M; Lozza A; Savasta S
    Childs Nerv Syst; 2016 Jan; 32(1):69-77. PubMed ID: 26584554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity.
    Belova AN; Shalenkov IV; Shakurova DN; Boyko AN
    Mult Scler; 2014 Dec; 20(14):1896-9. PubMed ID: 25145690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
    Sadaka Y; Verhey LH; Shroff MM; Branson HM; Arnold DL; Narayanan S; Sled JG; Bar-Or A; Sadovnick AD; McGowan M; Marrie RA; Banwell B;
    Ann Neurol; 2012 Aug; 72(2):211-23. PubMed ID: 22926854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applicability of McDonald 2010 and Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) 2016 Magnetic Resonance Imaging Criteria for the Diagnosis of Multiple Sclerosis in Sri Lanka.
    Gamage SMK; Wijeweera I; Wijesinghe P; Adikari SB; Fink K; Sominanda HMA
    J Clin Neurol; 2018 Jul; 14(3):339-344. PubMed ID: 29856160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low clinical conversion rate in clinically isolated syndrome patients - diagnostic benefit of McDonald 2010 criteria?
    Rosenkranz SC; Kaulen B; Neuhaus A; Siemonsen S; Köpke S; Daumer M; Stellmann JP; Heesen C
    Eur J Neurol; 2018 Feb; 25(2):247-e9. PubMed ID: 29024243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.
    Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B;
    Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thalamic atrophy is associated with development of clinically definite multiple sclerosis.
    Zivadinov R; Havrdová E; Bergsland N; Tyblova M; Hagemeier J; Seidl Z; Dwyer MG; Vaneckova M; Krasensky J; Carl E; Kalincik T; Horáková D
    Radiology; 2013 Sep; 268(3):831-41. PubMed ID: 23613615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis.
    Dalton CM; Brex PA; Miszkiel KA; Hickman SJ; MacManus DG; Plant GT; Thompson AJ; Miller DH
    Ann Neurol; 2002 Jul; 52(1):47-53. PubMed ID: 12112046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.